http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4652555-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75692a38a2eff0ee47b923b5ecb6bc79
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0075
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
filingDate 1982-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1987-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_013796925bcb14c4d346bc38dc00bfb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb5b76015f3dcd88731844bdf2013d8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2775e72c1342bd6f9264ffeeb89e518a
publicationDate 1987-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4652555-A
titleOfInvention Heparin compositions freed of mineral salts, particularly oxalates, and process for obtaining same
abstract This invention relates to oxalate-free preparations of heparin, particularly in the form of calcium salts of heparin, which can be used for the preparation of injectable solutions of heparin which have long storage life. n The invention is also directed to a process for freeing heparin from its oxalate content, such as by fractional precipitations by alcohol in the presence of adjusted amounts of mineral salt, until the heparin precipitated contains less than about 70 ppm of oxalate but may contain less than about 30 ppm, preferably even less than 20 ppm.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8435795-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9211305-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9540454-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7575886-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011112050-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9068957-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009061411-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9139876-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003203385-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE38743-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4977250-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7947507-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6448027-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8715953-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011207919-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011201572-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5110918-A
priorityDate 1977-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3135660-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4168377-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3482014-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136116304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID342

Total number of triples: 43.